We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
-$39.5M
Cap. Flow %
-27.17%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Buys

1
CNC icon
Centene
CNC
+$6.93M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.78M
3
UNH icon
UnitedHealth
UNH
+$3.65M
4
CVS icon
CVS Health
CVS
+$3.53M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M

Top Sells

1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

1 Healthcare 48.9%
2 Financials 13.82%
3 Technology 6.61%
4 Consumer Discretionary 5.8%
5 Materials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
251
Cardinal Health
CAH
$53.5B
– –
-13,598
Closed -$2.28M
CAPR icon
252
PUT
Capricor Therapeutics
CAPR
$1.13B
– –
-65,650
Closed -$5.48M
CASH icon
253
Pathward Financial
CASH
$1.89B
– –
-9,389
Closed -$743K
CI icon
254
Cigna
CI
$74.5B
– –
-3,618
Closed -$1.2M
COGT icon
255
PUT
Cogent Biosciences
COGT
$6.68B
– –
-59,797
Closed -$223K
COIN icon
256
Coinbase
COIN
$41.4B
– –
-2,359
Closed -$827K
CRDF icon
257
CALL
Cardiff Oncology
CRDF
$60.2M
– –
-479
Closed -$20.5K
CRDO icon
258
CALL
Credo Technology Group
CRDO
$37.8B
– –
-140
Closed -$94.5K
EHC icon
259
Encompass Health
EHC
$11.1B
– –
-29,226
Closed -$3.58M
ELDN icon
260
Eledon Pharmaceuticals
ELDN
$314M
– –
-14,855
Closed -$40.3K
ELEV
261
DELISTED
Elevation Oncology
ELEV
– –
-83,416
Closed -$30.6K
ESQ icon
262
Esquire Financial Holdings
ESQ
$1.06B
– –
-1,656
Closed -$157K
ETNB
263
DELISTED
89bio
ETNB
– –
-22,618
Closed -$222K
FISV
264
Fiserv Inc
FISV
$27B
– –
-3,752
Closed -$647K
GE icon
265
CALL
GE Aerospace
GE
$364B
– –
-40
Closed -$28.9K
GILD icon
266
Gilead Sciences
GILD
$167B
– –
-6,919
Closed -$767K
HOOD icon
267
Robinhood
HOOD
$89.7B
– –
-7,545
Closed -$823K
HUM icon
268
Humana
HUM
$48B
– –
-20,069
Closed -$4.91M
INSM icon
269
Insmed
INSM
$23.5B
– –
-8
Closed -$805
ITOS
270
DELISTED
iTeos Therapeutics
ITOS
– –
-47,512
Closed -$474K
LLY icon
271
CALL
Eli Lilly
LLY
$1.05T
– –
-23
Closed -$1.57K
LLY icon
272
Eli Lilly
LLY
$1.05T
– –
-3,404
Closed -$2.53M
MLTX icon
273
PUT
MoonLake Immunotherapeutics
MLTX
$1.64B
– –
-45,499
Closed -$1.48M
MRK icon
274
Merck
MRK
$315B
– –
-4,647
Closed -$368K
NBN icon
275
Northeast Bank
NBN
$1.13B
– –
-2,338
Closed -$208K
9 10
11
12 13

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.